SCHEMBL20054099

SCHEMBL20054099

CC1(C)OB(c2ccc(-c3cnc(CNC(=O)OCc4ccccc4)o3)cc2)OC1(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.48
KEAP1 Q14145 1/20 0.44
NFE2L2 Q16236 1/20 0.44
LIPG Q9Y5X9 2/20 0.41
LPL P06858 1/20 0.40
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
FFAR1 O14842 1/20 0.38
CCNE2 O96020 1/20 0.38
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38
NAMPT P43490 1/20 0.38
TNKS O95271 1/20 0.38
TNKS2 Q9H2K2 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14934909 0.81 KEAP1 (0.55) DGAT1KEAP1NFE2L2LIPGLPL
SCHEMBL16030765 0.81 KEAP1 (0.55) DGAT1KEAP1NFE2L2LIPGLPL
SCHEMBL15113138 0.80 ATM (0.45) DGAT1KEAP1NFE2L2LIPGLPL
SCHEMBL19388247 0.80 ATM (0.45) DGAT1KEAP1NFE2L2LIPGLPL
SCHEMBL16785551 0.77 HDAC1 (0.45) FFAR1TNKSTNKS2HDAC1HDAC6
SCHEMBL20054171 0.76 ATM (0.47) RXRARXRBRXRGCCNE2CCNE1
SCHEMBL29707329 0.75 CA2 (0.52) KEAP1NFE2L2LIPGLPLHDAC3
SCHEMBL29707332 0.75 CA2 (0.52) KEAP1NFE2L2LIPGLPLHDAC3
SCHEMBL16775744 0.75 ATM (0.43) FFAR1EPHX1
SCHEMBL30176163 0.75 L3MBTL1 (0.65) DGAT1KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019196-B1 COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-06-06 EP disclosed
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed